Julián Panés
Researcher Next ID · RN-029770
Researcher · Biochemistry, Genetics and Molecular Biology
Barcelona, Spain
- Works count
- 1,015
- Citation count
- 50,240
- H-index
- 108
- i10-index
- 411
Research interests
Publications
Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease
New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2212728
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)00581-5
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials
The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)00467-6
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1606910
Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study
The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)30570-6
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Gut · 2017 · 10.1136/gutjnl-2016-312735
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)31203-x
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
The American Journal of Gastroenterology · 2015 · https://doi.org/10.1038/ajg.2015.233
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
Clinical Gastroenterology and Hepatology · 2015 · https://doi.org/10.1016/j.cgh.2015.06.001
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(14)60661-9
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
Gut · 2014 · https://doi.org/10.1136/gutjnl-2013-306709
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
Journal of Crohn s and Colitis · 2013 · https://doi.org/10.1016/j.crohns.2013.02.020
Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease
Gastroenterology · 2013 · 10.1053/j.gastro.2013.10.055
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
Gastroenterology · 2013 · https://doi.org/10.1053/j.gastro.2013.06.009
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations
Journal of Crohn s and Colitis · 2012 · https://doi.org/10.1016/j.crohns.2012.09.005
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1112168
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease
Alimentary Pharmacology & Therapeutics · 2011 · https://doi.org/10.1111/j.1365-2036.2011.04710.x
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
Nature Genetics · 2011 · https://doi.org/10.1038/ng.764
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
Nature Genetics · 2010 · https://doi.org/10.1038/ng.717
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
Journal of Crohn s and Colitis · 2010 · https://doi.org/10.1016/j.crohns.2009.12.003
Development of the Crohnʼs disease digestive damage score, the Lémann score
Inflammatory Bowel Diseases · 2010 · https://doi.org/10.1002/ibd.21506
Magnetic resonance imaging for evaluation of Crohnʼs disease
Inflammatory Bowel Diseases · 2010 · https://doi.org/10.1002/ibd.21551
Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review
The American Journal of Gastroenterology · 2009 · https://doi.org/10.1038/ajg.2008.88
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease
Gut · 2009 · https://doi.org/10.1136/gut.2008.167957
Leukocyte-endothelial cell interactions: Molecular mechanisms and implications in gastrointestinal disease☆☆☆
Gastroenterology · 1998 · 10.1016/s0016-5085(98)70328-2
Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis
Gastroenterology · 1988 · https://doi.org/10.1016/0016-5085(88)90691-9
Current projects
No projects listed.